Opendata, web and dolomites

PUSHH SIGNED

Palaeoproteomics to Unleash Studies on Human History

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PUSHH project word cloud

Explore the words cloud of the PUSHH project. It provides you a very rough idea of what is the project "PUSHH" about.

competence    trained    objects    demand    degradation    molecular    revolutionised    biological    ancient    complementary    heritage    transferable    consolidating    modern    contribution    cultural    archaeological    specialists    human    evolution    valuable    disciplines    right    intersectoral    qualified    backgrounds    palaeontological    background    profiles    professional    palaeoproteomics    training    forming    network    archaic    multidisciplinary    admixture    adna    generation    sequencing    indirect    palaeoanthropologists    though    palaeontology    interaction    constructive    doctoral    longer    chemistry    push    archaeology    stimulating    archaeologists    limits    palaeoanthropological    understand    made    instead    palaeoanthropology    interdisciplinary    prepare    bioinformatics    million    few    stark    anatomically    mindset    skills    survive    transferrable    helping    older    contrast    proteins    direct    presently    tomorrow    advancing    phylogeny    international    expertise    materials    recovered    pushh    analytical    migration    partnership    retrieved    dna    palaeontologists    participating    oriented    humans   

Project "PUSHH" data sheet

The following table provides information about the project.

Coordinator
KOBENHAVNS UNIVERSITET 

Organization address
address: NORREGADE 10
city: KOBENHAVN
postcode: 1165
website: www.ku.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 3˙907˙265 €
 EC max contribution 3˙907˙265 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2020
 Duration (year-month-day) from 2020-03-01   to  2024-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) coordinator 1˙190˙088.00
2    MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV DE (MUENCHEN) participant 505˙576.00
3    DEVRO PLC UK (MODIESBURN CHRYSTON) participant 303˙172.00
4    UNIVERSITY OF YORK UK (YORK NORTH YORKSHIRE) participant 303˙172.00
5    UNIVERSITETET I BERGEN NO (BERGEN) participant 292˙342.00
6    UNIVERSITE DE BORDEAUX FR (BORDEAUX) participant 274˙802.00
7    UNIVERSITE DE PARIS FR (PARIS) participant 274˙802.00
8    UNIVERSITA DEGLI STUDI DI FIRENZE IT (Florence) participant 261˙499.00
9    CENTRO NACIONAL DE INVESTIGACION SOBRE LA EVOLUCION HUMANA ES (BURGOS) participant 250˙904.00
10    UNIVERSIDAD POMPEU FABRA ES (BARCELONA) participant 250˙904.00
11    UNIVERSITE PARIS DESCARTES FR (PARIS CEDEX 06) participant 0.00

Map

 Project objective

PUSHH will provide international, intersectoral and interdisciplinary doctoral training to prepare the next generation of palaeoanthropologists, palaeontologists and archaeologists to push knowledge on human biological and cultural evolution forward by using palaeoproteomics. Ancient DNA (aDNA) sequencing revolutionised our knowledge on evolution, migration and admixture of archaic and anatomically modern humans. However, no aDNA older than 0.7 million years has been retrieved yet. Ancient proteins instead survive much longer than aDNA, enabling molecular-based phylogeny beyond the limits of aDNA degradation. They can also be recovered from cultural heritage objects, helping to understand how they were made. Presently though, there are very few specialists that have been trained to analyse ancient proteins, in stark contrast to the study of aDNA. The growing demand of information provided by palaeoproteomics will require highly qualified specialists with a multidisciplinary background in analytical chemistry, bioinformatics, palaeoanthropology, palaeontology and archaeology and PUSHH will build that competence. The PUSHH network aims at: (i) forming, through research-based training, the professional profiles behind tomorrow’s state-of-the-art analysis of ancient proteins from palaeoanthropological, palaeontological and archaeological materials, (ii) consolidating existing constructive interaction across disciplines to focus different expertise and backgrounds into the common aim of advancing palaeoanthropology and archaeology, (iii) stimulating the development of an application-oriented mindset for direct or indirect exploitation of PUSHH R&D activities, through the right set of specific research-related and transferable skills. As a key PUSHH feature, the unique contribution provided by each participating institution will be integrated in a strong partnership to achieve valuable complementary research-specific and widely transferrable professional competence.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PUSHH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PUSHH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

MLFPM2018 (2019)

Machine Learning Frontiers in Precision Medicine

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More